Provided by Tiger Trade Technology Pte. Ltd.

Akari Therapeutics PLC

0.2612
+0.01516.14%
Volume:520.52K
Turnover:135.99K
Market Cap:11.96M
PE:-0.46
High:0.2750
Open:0.2310
Low:0.2310
Close:0.2461
52wk High:1.73
52wk Low:0.2178
Shares:45.78M
Float Shares:34.53M
Volume Ratio:3.68
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5691
EPS(LYR):-1.6570
ROE:-197.24%
ROA:-34.20%
PB:0.53
PE(LYR):-0.16

Loading ...

European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading

MT Newswires Live
·
4 hours ago

European Equities Traded in the US as American Depositary Receipts Start Week Lower

MT Newswires Live
·
Yesterday

Akari Therapeutics appoints Olga Anczukow to Scientific Advisory Board

Reuters
·
Feb 23

Akari Therapeutics Appoints Globally Recognized Expert in Rna Biology and Cancer Research, Olga Anczukow, Ph.d., to Its Scientific Advisory Board

THOMSON REUTERS
·
Feb 23

Akari Therapeutics to Present at 2026 Biocom Global Partnering & Investor Conference

Reuters
·
Feb 18

European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Tuesday Trading

MT Newswires Live
·
Feb 17

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Feb 13

European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading

MT Newswires Live
·
Feb 12

Akari Therapeutics CEO Highlights ADC Pipeline Expansion in Virtual Investor Interview

Reuters
·
Feb 11

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Feb 10

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Feb 06

Akari Therapeutics to Present Next-Generation ADC Platform at Webull Financial Virtual Conference

Reuters
·
Feb 05

European Equities Traded in the US as American Depositary Receipts Edge Lower in Friday Trading; Up for Week

MT Newswires Live
·
Jan 31

Akari Therapeutics files patent covering AKTX-102

TIPRANKS
·
Jan 26

Akari Therapeutics Files Patent Application for New ADC Candidate AKTX-102 Targeting CEACAM5 in Solid Tumors

Reuters
·
Jan 26

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 1.4% for Week

MT Newswires Live
·
Jan 24

Akari Therapeutics plc Announces Date for Upcoming Shareholder Meeting

Reuters
·
Jan 23

European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading

MT Newswires Live
·
Jan 16

BRIEF-Akari Therapeutics Releases CEO Corner Segment With CEO Abizer Gaslightwala

Reuters
·
Jan 09

Akari Therapeutics Highlights 2025 Progress and Plans Clinical Transition in 2026

Reuters
·
Jan 09